Yu Yao Selected Research

Ligands

1/2018	Cerebral ischemia induces angiogenesis in the peri-infarct regions via Notch1 signaling activation.
5/2016	Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma.
12/2012	ATP conditions intestinal epithelial cells to an inflammatory state that promotes components of DC maturation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Yao Research Topics

Disease

98	Neoplasms (Cancer) 02/2024 - 07/2002
34	Glioma (Gliomas) 01/2024 - 06/2009
19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 02/2003
17	Glioblastoma (Glioblastoma Multiforme) 11/2019 - 12/2010
16	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2013
14	Inflammation (Inflammations) 05/2024 - 01/2010
11	Breast Neoplasms (Breast Cancer) 04/2022 - 03/2015
9	Adenocarcinoma of Lung 02/2024 - 05/2016
8	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2015
8	Hypoxia (Hypoxemia) 10/2022 - 05/2015
8	Carcinogenesis 01/2022 - 06/2014
7	Sickle Cell Anemia (Hemoglobin S Disease) 01/2023 - 01/2016
6	Carcinoma (Carcinomatosis) 09/2023 - 09/2004
5	Medulloblastoma 02/2024 - 11/2012
5	Intervertebral Disc Displacement (Herniated Disc) 06/2022 - 10/2015
5	Pain (Aches) 06/2022 - 12/2014
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 03/2017
5	Brain Neoplasms (Brain Tumor) 01/2022 - 07/2014
5	Hepatocellular Carcinoma (Hepatoma) 08/2018 - 04/2009
4	Lymphatic Metastasis 09/2023 - 01/2013
4	Thalassemia 01/2023 - 01/2016
4	Epilepsy (Aura) 12/2022 - 12/2003
3	Ischemic Stroke 01/2024 - 04/2018
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 01/2022
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2023 - 01/2012
3	Obesity 01/2023 - 05/2015
3	Septic Shock (Toxic Shock Syndrome) 01/2023 - 01/2020
3	Melanoma (Melanoma, Malignant) 01/2023 - 02/2021
3	Thrombosis (Thrombus) 12/2022 - 02/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022 - 01/2020
3	Adenocarcinoma 11/2022 - 01/2021
3	Hypertension (High Blood Pressure) 01/2022 - 08/2012
3	Infarction (Infarctions) 04/2018 - 08/2005
3	Colorectal Neoplasms (Colorectal Cancer) 11/2014 - 01/2013
3	Ovarian Neoplasms (Ovarian Cancer) 12/2006 - 09/2004
2	Pneumonia (Pneumonitis) 02/2024 - 01/2023
2	Disease Progression 01/2024 - 12/2023
2	Infections 01/2024 - 12/2014
2	Conversion Disorder (Astasia Abasia) 10/2023 - 12/2020
2	Rectal Neoplasms (Rectal Cancer) 09/2023 - 01/2023

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2004
14	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2014
12	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2020
9	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2019
9	MicroRNAs (MicroRNA)IBA 03/2023 - 11/2009
9	AntigensIBA 01/2021 - 09/2005
8	Messenger RNA (mRNA)IBA 08/2023 - 09/2004
7	Peptides (Polypeptides)IBA 02/2024 - 01/2014
7	Small Interfering RNA (siRNA)IBA 09/2023 - 09/2013
7	GlobinsIBA 01/2023 - 01/2016
6	Tyrosine Kinase InhibitorsIBA 01/2024 - 08/2019
6	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
5	PlatinumIBA 01/2024 - 01/2020
5	Long Noncoding RNAIBA 03/2023 - 01/2017
5	Monoclonal AntibodiesIBA 05/2015 - 09/2005
4	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 01/2013
4	Fetal Hemoglobin (Hemoglobin F)IBA 01/2023 - 11/2019
4	EnzymesIBA 10/2022 - 09/2005
4	Circulating Tumor DNAIBA 02/2021 - 01/2017
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2018 - 03/2015
4	ChemokinesIBA 04/2018 - 01/2010
3	CollagenIBA 04/2024 - 05/2021
3	p38 Mitogen-Activated Protein KinasesIBA 01/2024 - 01/2010
3	CytokinesIBA 10/2023 - 04/2010
3	Interleukin-2 (IL2)IBA 10/2023 - 12/2006
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 08/2023 - 03/2016
3	Therapeutic UsesIBA 01/2023 - 02/2014
3	CateninsIBA 01/2023 - 11/2014
3	Bevacizumab (Avastin)FDA Link 03/2022 - 08/2012
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 06/2017
3	Carrier Proteins (Binding Protein)IBA 01/2022 - 04/2016
3	HydrogelsIBA 05/2021 - 03/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2016
3	Hyaluronic Acid (Hyaluronan)IBA 01/2019 - 03/2016
3	GoldIBA 01/2019 - 10/2017
3	LigandsIBA 01/2018 - 12/2012
3	Folic Acid (Vitamin M)FDA LinkGeneric 07/2017 - 03/2015
3	Lysine (L-Lysine)FDA Link 07/2016 - 03/2016
3	Temozolomide (Temodar)FDA LinkGeneric 06/2016 - 12/2010
3	FlagellinIBA 12/2012 - 01/2010
2	VaccinesIBA 01/2024 - 11/2018
2	LipopolysaccharidesIBA 01/2024 - 01/2022
2	Immune Checkpoint ProteinsIBA 01/2024 - 01/2020
2	Gemcitabine FDA Link 12/2023 - 01/2021
2	CarbonatesIBA 10/2023 - 12/2020
2	ElectrolytesIBA 10/2023 - 12/2020
2	Interleukin-8 (Interleukin 8)IBA 10/2023 - 01/2010
2	CreatinineIBA 09/2023 - 12/2022

Therapy/Procedure

45	Therapeutics 02/2024 - 12/2003
24	Drug Therapy (Chemotherapy) 12/2023 - 02/2003
18	Immunotherapy 02/2024 - 12/2006
9	Radiotherapy 02/2024 - 08/2012
4	Diskectomy (Discectomy) 06/2022 - 01/2016
4	Transplantation 01/2022 - 12/2008
3	Neoadjuvant Therapy 01/2024 - 01/2022
3	Cystectomy 12/2023 - 01/2022
3	Precision Medicine 01/2019 - 01/2017
3	Photothermal Therapy 01/2019 - 10/2017
2	Punctures 01/2024 - 01/2024
2	Length of Stay 01/2024 - 12/2014